Query author contributions in Reactome Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome .
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person chylomicron => TG-depleted chylomicron + 50 long-chain fatty acids + 50 diacylglycerols
Class:Id Reaction:174757
_displayName chylomicron => TG-depleted chylomicron + 50 long-chain fatty acids + 50 diacylglycerols
_doRelease TRUE
_timestamp 2017-02-16 16:16:07
authored [InstanceEdit:197113] D'Eustachio, P, 2007-04-30 14:19:38
catalystActivity [CatalystActivity:174759] lipoprotein lipase activity of GPIHBP1:HSPG:LPL dimer [plasma membrane]
compartment [Compartment:984] extracellular region [Compartment:876] plasma membrane
created [InstanceEdit:174717] D'Eustachio, P, 2006-02-20 17:46:54
edited [InstanceEdit:174830] D'Eustachio, P, 2006-02-20 18:35:05
input [Complex:174697] chylomicron [extracellular region] [Homo sapiens]
literatureReference [LiteratureReference:174794] Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase [LiteratureReference:174613] Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies [LiteratureReference:174715] Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein [LiteratureReference:174641] Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway [LiteratureReference:174821] Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment
modified [InstanceEdit:174829] D'Eustachio, P, 2006-02-20 18:48:49 [InstanceEdit:177294] D'Eustachio, P, 2006-03-27 18:45:57 [InstanceEdit:197114] D'Eustachio, P, 2007-04-30 14:20:20 [InstanceEdit:216771] D'Eustachio, P, 2008-03-21 20:40:11 [InstanceEdit:1043153] Wu, G, 2010-11-19 [InstanceEdit:8946993] Shorser, Solomon, 2016-11-07 [InstanceEdit:8963894] D'Eustachio, Peter, 2017-02-13 [InstanceEdit:8964195] D'Eustachio, Peter, 2017-02-15 [InstanceEdit:8964415] D'Eustachio, Peter, 2017-02-16 [InstanceEdit:9606200] Wu, G, 2018-04-19 [InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
name chylomicron => TG-depleted chylomicron + 50 long-chain fatty acids + 50 diacylglycerols
output [Complex:174798] TG-depleted chylomicron [extracellular region] [Homo sapiens] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174675] DAGs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region] [SimpleEntity:174602] LCFAs [extracellular region]
precedingEvent
regulatedBy [PositiveRegulation:174621] Positive regulation by 'APOC2 [extracellular region]' [NegativeRegulation:174677] Negative regulation by 'APOC3 [extracellular region]' [PositiveRegulation:174695] Positive regulation by 'APOA5 [extracellular region]'
releaseDate 2005-09-26
reviewStatus [ReviewStatus:9821382] five stars
species [Species:48887] Homo sapiens
stableIdentifier [StableIdentifier:359278] R-HSA-174757.5
summation [Summation:174793] Lipoprotein lipase dimers (LPL:LPL) are tethered to heparan ...
(hasEvent) [Pathway:8963901] Chylomicron remodeling [Homo sapiens]
(precedingEvent) [Reaction:174690] TG-depleted chylomicron + spherical HDL => chylomicron remnant + spherical HDL:apoA-I:apoA-II:apoA-IV:apoC-II:apoC-III [Homo sapiens]
(updatedInstance) [_UpdateTracker:9788258] Update Tracker - [Reaction:174757] chylomicron => TG-depleted chylomicron + 50 long-chain fatty acids + 50 diacylglycerols - v43:[modifyText] [_UpdateTracker:9788474] Update Tracker - [Reaction:174757] chylomicron => TG-depleted chylomicron + 50 long-chain fatty acids + 50 diacylglycerols - v42:[modifyText]
[Change default viewing format]
List...
Protein identifiers
ChEBI identifiers
KEGG COMPOUND identifiers
No pathways have been reviewed or authored by chylomicron => TG-depleted chylomicron + 50 long-chain fatty acids + 50 diacylglycerols (174757)